Table 3.
Patients, sex, age | ASAT IU/1 | ALAT IU/l | HCV RNA | Knodell index | Cryo type | Clinical symptoms |
---|---|---|---|---|---|---|
1. M, 61 | 11 | 20 | + | 5 | III | S, J, DT, PN, K |
2. M, 63 | 34 | 17 | + | 11 | II | S, J, K (MPGN) |
IgMκ | ||||||
3. F, 36 | 21 | 16 | + | 2 | II | S, PN, CNS, K |
IgMκ | ||||||
4. M, 60 | 9 | 50 | + | 7 | II | S, J, PN, GS |
IgMκ | ||||||
5. F, 72 | 60 | 75 | + | ND | II | S, J, K (MPGN) |
IgMκ | ||||||
6. M, 71 | 90 | 120 | + | 6 | II | S, J, PN, GS |
IgMλ | ||||||
7. F, 81 | 24 | 32 | + | 6 | II | S, PN, GS |
IgMκ | ||||||
8. M, 58 | 73 | 60 | + | 8 | II | S, PN |
IgMλ | ||||||
9. F, 66 | 77 | 62 | + | 6 | II | S, J, PN |
IgMκ | ||||||
10. F, 74 | 70 | 40 | + | 10 | II | S, J, PN |
IgMκ | ||||||
11. F, 59 | 52 | 65 | + | 7 | III | S, PN |
12. M, 81 | 30 | 41 | + | ND | II | S, PN, CNS |
IgMκ | ||||||
13. F, 70 | 100 | 120 | + | ND | II | S, PN, GS |
IgMκ | ||||||
14. M, 71 | 22 | 40 | + | 5 | II | S, DT, K (MPGN) |
IgMκ | ||||||
15. F, 62 | 68 | 85 | + | 10 | II | S, J, PN |
IgMκ | ||||||
16. M, 72 | 28 | 35 | + | 5 | III | S, PN, GS |
17. F, 54 | 200 | 300 | + | 11 | II | S, PN |
IgMκ | ||||||
18. F, 76 | 40 | 46 | + | 5 | II | S, J, PN |
IgMκ |
S: skin, J: joints, DT: digestive tract, K: kidney, MPGN: mem-branoproliferative glomerulonephritis, PN: peripheral nerve, CNS: central nervous system, GS: general symptoms (fever, weight loss).